Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 41.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 160.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 701
  • Market Cap: £15.67m
  • Beta: 0.01

Regulatory News

Director/PDMR Dealing 21-May-2025 07:00 RNS
Arecor Partnership with Skye Bioscience 19-May-2025 07:00 RNS
Director Dealing 14-May-2025 14:37 RNS
Arecor sells rights to non-Ogluo® products 08-May-2025 07:00 RNS
Posting of 2024 Annual Report and Notice of AGM 06-May-2025 16:42 RNS
Grant of Options and PDMR Dealing 23-Apr-2025 07:00 RNS
Final results for 2024 22-Apr-2025 07:00 RNS
Notice of Results 10-Apr-2025 07:00 RNS
Collaboration with global pharmaceutical partner 26-Mar-2025 07:00 RNS
Arecor partnership with biopharmaceutical company 12-Mar-2025 07:00 RNS
Arecor Full Year 2024 Trading Update 03-Feb-2025 07:00 RNS
Orderly Cessation of Tetris Pharma Operations 10-Jan-2025 07:45 RNS
Change of Nominated Advisor and Joint Broker 09-Jan-2025 07:00 RNS
Arecor Signs Exclusive Licensing Agreement 30-Dec-2024 07:00 RNS
Grant of Options and PDMR Dealing 02-Dec-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 41.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 160.00
52 Week Low 38.00
Volume 701
Shares Issued 37.76m
Market Cap £15.67m
Beta 0.01

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Trend
92.98% below the market average92.98% below the market average92.98% below the market average92.98% below the market average92.98% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average
Income Not Available
Growth
41.76% above the market average41.76% above the market average41.76% above the market average41.76% above the market average41.76% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

AREC Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
11:42 698 @ 42.94p
10:23 3 @ 43.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page